<DOC>
	<DOCNO>NCT00824083</DOCNO>
	<brief_summary>The purpose study assess functional outcome , quality life late sequela representative sample 600 long-term survivor Ewing sarcoma build unique clinical functional data pool underlie cohort 3000 Ewing sarcoma patient follow-up 3 decade .</brief_summary>
	<brief_title>Functional Clinical Long-Term Outcome Ewing Sarcoma Treatment</brief_title>
	<detailed_description>Trial objective : As survival rate bone sarcoma patient raise owe improve treatment strategy focus investigation medical , social , economic sequela intensive multimodal treatment . This study aim assess functional outcome , quality life late sequela representative sample long-term survivor Ewing sarcoma . The data record combined standardized treatment data cover 30-year period produce data pool unique magnitude use development guideline improvement future bone sarcoma treatment . Working plan : The work plan provide assessment functional outcome quality life mean validated tool ( TESS , SF36 , PEDQOL ) objectively measure daily activity pattern use Step Activity Monitor ( SAM ) 600 long-term Ewing sarcoma survivor control group 300 match healthy subject . Information sarcoma treatment follow-up obtain re-structuring complement database relevant patient cohort ( n=3000 ) four consecutive nationwide international clinical trial 1980 2008 . Procedures local treatment evaluate regard functional outcome , quality life , survival probability prognostic factor predict long-term outcome identify . Exploitation result : The result present scientific meeting publish international journal . Guidelines develop regard improvement treatment , rehabilitation , social integration bone sarcoma patient utilized guide patient decision process medical professional regard treatment . In long run , evidence base guideline treatment follow-up transfer health system .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Sarcoma , Ewing</mesh_term>
	<criteria>CESS81/CESS86/EICESS92/EUROE.W.I.N.G.99 trial participant German Society Pediatric Hematology Oncology ( GPOH ) complete remission ( CR ) kind paralysis &lt; 3y diagnosis</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>bone tumor</keyword>
	<keyword>long-term function</keyword>
	<keyword>daily activity</keyword>
	<keyword>late sequela</keyword>
</DOC>